GI
GILD icon

GAMMA Investing’s Gilead Sciences GILD Stock Holding History

GAMMA Investing’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.71M Buy
38,323
+3,577
+10% +$502K 0.19% 82
2026
Q2 		$4.39M Buy
34,746
+598
+2% +$78.8K 0.16% 92
2026
Q1 		$4.76M Buy
34,148
+3,193
+10% +$447K 0.22% 69
2025
Q4 		$3.8M Buy
30,955
+3,537
+13% +$430K 0.19% 76
2025
Q3 		$3.04M Buy
27,418
+1,799
+7% +$204K 0.17% 91
2025
Q2 		$2.84M Buy
25,619
+2,859
+13% +$304K 0.18% 87
2025
Q1 		$2.55M Buy
22,760
+4,532
+25% +$468K 0.19% 88
2024
Q4 		$1.68M Buy
18,228
+2,955
+19% +$266K 0.14% 123
2024
Q3 		$1.28M Buy
15,273
+5,333
+54% +$407K 0.13% 152
2024
Q2 		$682K Buy
9,940
+3,567
+56% +$238K 0.09% 197
2024
Q1 		$467K Sell
6,373
-336
-5% -$25.8K 0.1% 198
2023
Q4 		$525K Buy
+6,709
New +$522K 0.14% 120

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

GAMMA Investing's GILD Position: Q3 2026 in Review

GAMMA Investing increased its Gilead Sciences (GILD) stake by 10% in Q3 2026, buying an estimated $502K and bringing the position to 38,323 shares worth $5.71M. The position accounts for 0.19% of the portfolio, ranked #82.

GAMMA Investing first reported a position in GILD in Q4 2023 and has held it in 12 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • GAMMA Investing held 38,323 shares of Gilead Sciences worth $5.71M as of Q3 2026.
  • GAMMA Investing bought 3,577 Gilead Sciences shares in Q3 2026, an estimated $502K.
  • Gilead Sciences made up 0.19% of GAMMA Investing's portfolio in Q3 2026, its #82 holding.
  • GAMMA Investing first reported a position in Gilead Sciences in Q4 2023 and has held it in 12 quarters since.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.